Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TALVEY® (talquetamab-tgvs)

Medical Information

+ Save link

TALVEY - Preparation and Administration Using Aseptic Technique in Clinical Trials

Last Updated: 08/06/2024

Summary

Aseptic technique must be used to prepare and administer TALVEY.¹
In clinical trials, TALVEY was prepared using aseptic technique. It was preferred that the preparation of the product be performed under a laminar flow hood (LFH) or biological safety cabinet (BSC).¹

Literature Search

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 05 August 2024.

References

Show

1	Data on File. Talquetamab. Investigational product preparation and administration instruction for subcutaneous administration of 2 mg/mL (3 mg) and 40 mg/mL (40 mg). Janssen Research and Development, LLC. TV-TEC-207195; version 5.0; 2024.